Crystagen, a short peptide with a sequence of Glu-Asp-Pro, is gaining attention in the scientific community for its potential to improve immune function, combat age-related changes, and enhance overall health. This peptide, with a molecular weight of 359.33 g/mol, is stored under conditions of -20 °C and is primarily used for research in peptides and immune modulation.
Crystagen: Unveiling the Secrets of Immune Enhancement
Immune-Promoting Potential of Crystagen
Crystagen’s role in promoting immune health and well-being is an exciting area of research. Studies suggest this peptide has immunomodulatory effects, such as normalizing the immunogram, amplifying T-cell activity, maintaining thymic integrity, and stimulating immune cell proliferation.
In a 2014 study titled “Age-related molecular aspects of the immunomodulating activity of peptides in the spleen,” researchers found that Crystagen and other short peptides showed various immunoprotective effects in the spleen during their ageing. Both Vilon and Crystagen were found to activate T-helpers, with the impact of Vilon being provided by a decreased level of apoptosis and Crystagen increasing proliferation and differentiation processes [^1^].
Crystagen’s Potential Antitumor Activity and Impact on Athletes
In addition to its immune-promoting potential, Crystagen has demonstrated potential antitumor activity. It has also been found to reduce the incidence of respiratory viral infections in athletes, making it a promising area of research for sports medicine.
Dosage and Administration
Crystagen is typically administered at a dosage of 1mg per day; this daily dose is believed to be effective in harnessing the potential benefits of Crystagen, although individual needs may vary.
The Future of Crystagen Research
While the current research on Crystagen is promising, it’s important to note that much of the research is still in its early stages. As we continue to explore the potential of this peptide, we look forward to uncovering more about its potential benefits and applications.
In conclusion, Crystagen is a peptide of significant interest due to its potential immunomodulatory effects and its potential to improve overall health. As research continues, we may discover even more benefits and applications for this promising peptide.
Chervyakova, N. A., et al. “Age-Related Molecular Aspects of Immunomodulating Activity of Peptides in the Spleen.”Advances in Gerontology, Mar. 2014. Springer Nature, https://doi.org/10.1134/s2079057014010020.
Chervyakova, N. A., et al. “Age-Related Molecular Aspects of Immunomodulating Activity of Peptides in the Spleen.” Advances in Gerontology, Mar. 2014. Springer Nature, https://doi.org/10.1134/s2079057014010020.
